Neuro-Bio is delighted to welcome Nathalia Mayag Medina as part of the team. Nathalia recently graduated in pharmacy at University of Barcelona. The Pharmaceutical Sciences degree is a 5-year programme during which she was able to join two projects. First, a directed project regarding amyloid aggregate dyes such as Congo red. Second, a thesis about antiviral’s synthesis at the department of Medicinal Chemistry at KU Leuven, Belgium, during the Erasmus + studies programme. Lastly, she spent one month in Seoul, South Korea, at Sookmyung Women’s University at a Plant metabolomics laboratory thanks to the pharmacy Student Exchange Programme (SEP). Nevertheless, her true passion is neuroscience, so she came to Neuro-Bio Ltd. to be able to study Alzheimer’s disease and contribute to this novel approach they present.
LATEST NEWS
- Neuro-Bio’s first paper of 2026 has been published!
- Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
- CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures
- CEO & Founder Baroness Susan Greenfield visits San Raffaele Hospital in Milan!
- Neuro-Bio featured in Corriere Salute – a health & wellbeing section of Corriere della Sera, one of Italy’s most established and widely read national newspapers!